Transvaginal mesh is used to treat patients with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). As a national law firm representing individuals who believe their injuries (stem) from…
Read More
In a letter from the U.S. Food and Drug Administration (FDA) dated September 19, 2012, Zimmer Holdings Inc. was issued a warning regarding their hip replacement device known as the…
Read More
The U.S. Food and Drug Administration (FDA) recently ordered that an update be made to the drug labels for fluoroquinolone medications, which includes the antibiotic drug Levaquin. Released on August…
Read More
A plaintiff in a transvaginal mesh lawsuit in West Virginia will soon know the outcome of her case against C. R. Bard. The first bellwether trial in the C. R.…
Read More
The deposition of a former C.R. Bard president responsible for the creation and promotion of C.R. Bard's Avaulta mesh product was played for the jury on August 6 in a…
Read More
Boston Scientific recently contributed a $1 million research grant to the Pelvic Floor Disorders Network (PFDN). The research funds will be used in the SUPeR clinical trial, a study examining…
Read More
July 13, 2013 marks two years since the release of the transvaginal mesh safety communication issued by the U.S. Food and Drug Administration (FDA) regarding transvaginal mesh products used to…
Read More
Submit Your Claim According to a Reuters report published on March 12, the U.S. Food and Drug Administration (FDA) has sent Stryker a warning letter about its business practices and…
Read More
Around the country, individuals have been filing DePuy ASR Hip Replacement lawsuits, and a handful of these suits are slated to begin trial later this year. DePuy ASR Hip Replacement…
Read More
Plaintiffs in a lawsuit filed against Boston Scientific Corporation have ordered the release of documents relating to Boston Scientific's ProteGen product, a vaginal mesh sling device made out of woven…
Read More